Aktiesnakken — August 2010
-
hvad er det for et fase 3, er det bendamustine
-
hvad er prisen på det europæiske marked for arzerra
-
og så er der de andre indikationer
-
de alternative muligheder for fabrikken. Er I dialog
-
omkring Q1
-
Jan tager dem
-
^^Dagen efter generalforsamling . kan ikke huske hvornår
-
ja det er bendamustine og den kommer nu!
-
intet svar på pris
-
men han gætter nok rigtigt!!!
-
hahaha
-
love it
-
GSK forventer reimbursement online i de kommende måneder
-
dlbcl var heavily retreated
-
vi er helt sikrer på at der skal kombinationsbehandling til
-
ex-datoen for at få udbytte i FLS var den 19.04.2010
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind